Baidu
map

International journal of Epidemiology: 儿童对未来体育活动的期望是否能预测他们成年后的体育活动?

2021-01-29 MedSci原创 MedSci原创

11岁时对体育活动的认同与期待对未来的体育活动有着长远的影响

规律的体育活动(physical activity PA)有益身心,然而,很大一部分人都没有达到推荐的活动量。追踪研究发现,PA在整个青春期都会减少,而在成年后,PA的水平和强度继续下降。不过PA的变化轨迹存在相当大的个体差异。

PA与一系列因素相关,包括性别和年龄、个性、身心健康、社会规范和习俗、社会支持以及学校和社区特点。许多现有的干预措施侧重于制定方案政策等,来支持和推动人们更积极进行体育活动。虽然许多措施已被证明是成功的,但它们对不同人的效果不同,对某些人的效果更好。如果能了解不同PA轨迹的影响因素,那么就能使干预措施更有针对性,更有效。

一个人过去的经历、观念、认知和习惯会影响以后的行为,包括对干预措施的接受和参与。其中一个就是一个人对体育活动的认同(physical activity identity PAI),也就是说一个人将体育活动视为自己的核心的程度。研究发现,无论是儿童还是成人,更大的PAI与当时更高的活动水平相关。但这些研究大部分是横断面的,并且使用自我报告工具来测量成人、青少年或儿童的PAI。很少研究分析PAI与未来体育活动的关系。

因此,Benedetta Pongiglione等人利用(i)11岁时写的文章;(ii)机器学习技术;(iii)从一个随访五十年的大型队列中收集的纵向数据,来研究童年时表达的PAI能在多大程度上预测成年后的PA水平和PA变化轨迹。

该研究基于英国的国家儿童发展研究,对超过17 000人的一生进行了跟踪调查。受试者11岁时被邀请写作30分钟回答一个问题:"想象你现在25岁。写下你在25岁时的生活、兴趣、家庭生活和工作情况。“ 然后研究者用机器学习技术自动识别提到体育活动的文章,包括直接参与活动作为旁观者观看他人参与体育活动。研究者还随访了受试者23岁、33岁、42岁、50岁和55岁时的体育活动情况。据此分析童年PAI与23岁至55岁的活动水平以及与变化轨迹的相关程度。

结果发现:42.2%的男性和33.5%的女性在他们的文章中提到了体育活动,描述了主动和/或被动参与体育活动。在男性中,儿童时期主动参与的PAI与成年期较高的活动水平相关,但在女性中无关。作为旁观者被动参与的PAI与任何性别的体育活动都无关

这项研究提供了一种新的方法来分析大型定性数据集,进而评估认知和行为。11岁时对体育活动的认同与期待对未来的体育活动有着长远的影响

 

 

参考文献

Pongiglione B, Kern ML, Carpentieri JD, Schwartz HA, Gupta N, Goodman A. Do children's expectations about future physical activity predict their physical activity in adulthood? Int J Epidemiol. 2020 Oct 1;49(5):1749-1758. doi: 10.1093/ije/dyaa131. PMID: 33011758; PMCID: PMC7746399.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1898705, encodeId=f7e31898e0591, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Jan 30 19:25:48 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008781, encodeId=692b2008e818a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 08 03:25:48 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884938, encodeId=ccf918849381d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Feb 24 12:25:48 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921197, encodeId=07a792119ebc, content=这个研究方法挺有意思的, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/83e3fa33814e486397b1a592cee4c53e/f39df914273d4cd09bc74b63d0c23594.jpeg, createdBy=549f5451181, createdName=Tian, createdTime=Fri Jan 29 20:49:45 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920950, encodeId=1a25920950b3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/d719c5a457e640d88a16efd137890639/57d598105aeb4783b9073e2f13733562.jpg, createdBy=73dc5434031, createdName=ms3000000503829460, createdTime=Fri Jan 29 10:30:54 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920905, encodeId=c4399209050a, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Jan 29 07:09:27 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1898705, encodeId=f7e31898e0591, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Jan 30 19:25:48 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008781, encodeId=692b2008e818a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 08 03:25:48 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884938, encodeId=ccf918849381d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Feb 24 12:25:48 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921197, encodeId=07a792119ebc, content=这个研究方法挺有意思的, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/83e3fa33814e486397b1a592cee4c53e/f39df914273d4cd09bc74b63d0c23594.jpeg, createdBy=549f5451181, createdName=Tian, createdTime=Fri Jan 29 20:49:45 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920950, encodeId=1a25920950b3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/d719c5a457e640d88a16efd137890639/57d598105aeb4783b9073e2f13733562.jpg, createdBy=73dc5434031, createdName=ms3000000503829460, createdTime=Fri Jan 29 10:30:54 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920905, encodeId=c4399209050a, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Jan 29 07:09:27 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2022-01-08 仁者大医
  3. [GetPortalCommentsPageByObjectIdResponse(id=1898705, encodeId=f7e31898e0591, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Jan 30 19:25:48 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008781, encodeId=692b2008e818a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 08 03:25:48 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884938, encodeId=ccf918849381d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Feb 24 12:25:48 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921197, encodeId=07a792119ebc, content=这个研究方法挺有意思的, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/83e3fa33814e486397b1a592cee4c53e/f39df914273d4cd09bc74b63d0c23594.jpeg, createdBy=549f5451181, createdName=Tian, createdTime=Fri Jan 29 20:49:45 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920950, encodeId=1a25920950b3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/d719c5a457e640d88a16efd137890639/57d598105aeb4783b9073e2f13733562.jpg, createdBy=73dc5434031, createdName=ms3000000503829460, createdTime=Fri Jan 29 10:30:54 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920905, encodeId=c4399209050a, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Jan 29 07:09:27 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-02-24 liye789132251
  4. [GetPortalCommentsPageByObjectIdResponse(id=1898705, encodeId=f7e31898e0591, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Jan 30 19:25:48 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008781, encodeId=692b2008e818a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 08 03:25:48 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884938, encodeId=ccf918849381d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Feb 24 12:25:48 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921197, encodeId=07a792119ebc, content=这个研究方法挺有意思的, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/83e3fa33814e486397b1a592cee4c53e/f39df914273d4cd09bc74b63d0c23594.jpeg, createdBy=549f5451181, createdName=Tian, createdTime=Fri Jan 29 20:49:45 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920950, encodeId=1a25920950b3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/d719c5a457e640d88a16efd137890639/57d598105aeb4783b9073e2f13733562.jpg, createdBy=73dc5434031, createdName=ms3000000503829460, createdTime=Fri Jan 29 10:30:54 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920905, encodeId=c4399209050a, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Jan 29 07:09:27 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-01-29 Tian

    这个研究方法挺有意思的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1898705, encodeId=f7e31898e0591, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Jan 30 19:25:48 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008781, encodeId=692b2008e818a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 08 03:25:48 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884938, encodeId=ccf918849381d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Feb 24 12:25:48 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921197, encodeId=07a792119ebc, content=这个研究方法挺有意思的, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/83e3fa33814e486397b1a592cee4c53e/f39df914273d4cd09bc74b63d0c23594.jpeg, createdBy=549f5451181, createdName=Tian, createdTime=Fri Jan 29 20:49:45 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920950, encodeId=1a25920950b3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/d719c5a457e640d88a16efd137890639/57d598105aeb4783b9073e2f13733562.jpg, createdBy=73dc5434031, createdName=ms3000000503829460, createdTime=Fri Jan 29 10:30:54 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920905, encodeId=c4399209050a, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Jan 29 07:09:27 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-01-29 ms3000000503829460

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1898705, encodeId=f7e31898e0591, content=<a href='/topic/show?id=1fa568e6ec' target=_blank style='color:#2F92EE;'>#epidemiology#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6876, encryptionId=1fa568e6ec, topicName=epidemiology)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sat Jan 30 19:25:48 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008781, encodeId=692b2008e818a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat Jan 08 03:25:48 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884938, encodeId=ccf918849381d, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Feb 24 12:25:48 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921197, encodeId=07a792119ebc, content=这个研究方法挺有意思的, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210131/83e3fa33814e486397b1a592cee4c53e/f39df914273d4cd09bc74b63d0c23594.jpeg, createdBy=549f5451181, createdName=Tian, createdTime=Fri Jan 29 20:49:45 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920950, encodeId=1a25920950b3, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210128/d719c5a457e640d88a16efd137890639/57d598105aeb4783b9073e2f13733562.jpg, createdBy=73dc5434031, createdName=ms3000000503829460, createdTime=Fri Jan 29 10:30:54 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920905, encodeId=c4399209050a, content=好文章,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Jan 29 07:09:27 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-01-29 yangchou

    好文章,谢谢分享

    0

相关资讯

2019 加拿大指南:妊娠期间体育活动

加拿大妇产科医生协会(SOGC)联合加拿大运动生理学会(CSEP)共同发布了妊娠期间体育活动指南,主要目的是面向妊娠女性和产科护理以及运动专家针对孕期体育活动提供指导建议。

BMJ:体育活动与死亡风险研究

研究认为,即使对于基线体力活动较低的中老年人群,都可以通过增加体力活动而获得相当大的长寿益处

JAHA:体育活动量和方式与动脉僵硬度之间的关联

高强度体育活动与较低的颈动脉至股动脉脉搏波速度有关,但定期活动者与周末或兼职时参加剧烈运动者之间没有差异。

Baidu
map
Baidu
map
Baidu
map